Our ALDS PRO takes lung health assessment to the next level by adding FENO (Fractional Exhaled Nitric Oxide) to the capabilities of the ALDS, creating a complete system for comprehensive diagnostics and therapeutic planning.
Precise Insights, Empowering Better Decisions
All in one portable solution
Functions
Oscillometry, spirometry and FENO Integration: Combines standard oscillometry and spirometry measurements (FEV1, FVC) with FENO to provide a comprehensive analysis of lung function and airway inflammation.
Advanced Airway Inflammation Monitoring: Accurately measures fractional exhaled nitric oxide (FENO), a key biomarker for airway inflammation, helping detect conditions like asthma and COPD.
Real-Time Data: Delivers quick, actionable feedback to healthcare professionals for faster decision-making and timely interventions.
Applications
Chronic Respiratory Conditions: Ideal for diagnosing and managing asthma, COPD, and other pulmonary diseases, offering detailed insights into both airflow obstruction and airway inflammation.
Non-Invasive Patient Monitoring: Ensures patient comfort while providing reliable, non-invasive measurements for ongoing monitoring.
Outpatient Clinics: Perfect for busy healthcare settings, providing quick, accurate, and portable diagnostic capabilities without compromising data quality.
Therapeutic Support
Improved Diagnosis: The combination of oscillometry, spirometry and FENO provides a comprehensive picture of lung health, enabling earlier intervention and more accurate treatment plans.
Optimized Treatment Planning: Helps healthcare professionals make data-driven therapeutic decisions, improving patient care and outcomes.
Efficient Workflow: Streamlines clinic operations by offering a portable, all-in-one diagnostic device that enhances workflow efficiency while maintaining high data quality.
